Blood glucose control in T2D: early, proactive intervention and how to optimise patient outcomes

AUS

$0

free

RACGP CPD Program

1 hr

Endocrinology

2 Credits

Course Description

This continuing medical education program is designed to provide general practitioners with an up-to-date approach to the management of diabetes, with the aim of optimising outcomes for their patients. The program has an emphasis on the role of DPP4 inhibitors, and their place in the 2020 Australian Diabetes Society and RACGP type 2 diabetes management algorithm.


This program is supported by an independent educational grant provided by MSD.

Course Details

Expiry Date: 2022-08-27

Professions: Physician

Faculty

Dr Gary Deed
MBBS, MRACGP

Dr Ivan Kuo
MBBS, FRACP, Endocrinologist

Accreditation

This Active Learning Module has been approved by RACGP CPD Program for 2 CPD points.

Activity no. 215562

Members are able to claim CPD activity points for 2 points through ‘Quick log’ on their RACGP CPD Dashboard.

Learning Objective(s)

Upon completion of this continuing education program participants will be better able to:

  • Describe the importance of early and proactive
    glycaemic management
  • Optimise patient outcomes by increasing vigilance
    around timely monitoring of HbA1c and early and proactive treatment escalation
  • Identify clinical and patient factors that can impact
    the efficacy of a glucose-lowering medicine to reduce HbA1c
  • Implement shared decision making strategies to
    select the most appropriate glucose-lowering regimen for individual patients
    with type 2 diabetes